{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:46:14Z","timestamp":1788824774583,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KL1353"],"award-info":[{"award-number":["KL1353"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.atherosclerosis.2004.03.020","type":"journal-article","created":{"date-parts":[[2004,6,12]],"date-time":"2004-06-12T12:41:09Z","timestamp":1087044069000},"page":"221-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells"],"prefix":"10.1016","volume":"175","author":[{"given":"Mariam","family":"Klouche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Peri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Knabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns-Henning","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz-Xaver","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB1","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/01.CIR.95.4.1062","article-title":"Conner memorial lecture. Oxidative modification of LDL and atherogenesis","volume":"95","author":"Steinberg","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB2","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.81.12.3883","article-title":"Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids","volume":"81","author":"Steinbrecher","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB3","first-page":"915","article-title":"Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N Engl J Med."},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB4","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.87.13.5134","article-title":"Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells","volume":"87","author":"Cushing","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00004872-200106000-00011","article-title":"Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation","volume":"19","author":"Watanabe","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.ATV.14.1.32","article-title":"Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL","volume":"14","author":"Yl\u00e4-Herttuala","year":"1994","journal-title":"Arterioscler Thromb."},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.ATV.18.3.369","article-title":"Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion","volume":"18","author":"Torzewski","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB8","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.182.6.1959","article-title":"On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety","volume":"182","author":"Bhakdi","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/01.ATV.18.9.1376","article-title":"Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages","volume":"18","author":"Klouche","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB10","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/01.CIR.101.15.1799","article-title":"Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation","volume":"101","author":"Klouche","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB11","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1161\/01.CIR.0000038366.11851.D0","article-title":"Enzymatically modified nonoxidized low-density lipoprotein induces interleukin-8 in human endothelial cells: role of free fatty acids","volume":"106","author":"Suriyaphol","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.ATV.19.3.784","article-title":"Enzymatically modified","volume":"19","author":"Klouche","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB13","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1161\/01.ATV.19.10.2348","article-title":"Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation","volume":"19","author":"Bhakdi","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/hc0702.104126","article-title":"Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein","volume":"105","author":"Rossi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1385\/IR:24:2:163","article-title":"C-reactive protein, inflammation, and innate immunity","volume":"24","author":"Mortensen","year":"2001","journal-title":"Immunol Res"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/0929866023408779","article-title":"The systemic reaction during inflamation: the acute-phase proteins","volume":"9","author":"Ceciliani","year":"2002","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1146\/annurev.immunol.15.1.797","article-title":"Gp130 and the interleukin-6 family of cytokines","volume":"15","author":"Taga","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB19","doi-asserted-by":"crossref","first-page":"22190","DOI":"10.1016\/S0021-9258(18)41653-5","article-title":"Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component","volume":"267","author":"Breviario","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB20","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4049\/jimmunol.150.5.1804","article-title":"TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute-phase proteins","volume":"150","author":"Lee","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB21","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.4049\/jimmunol.153.8.3700","article-title":"Relationship of TSG-14 protein to the pentraxin family of major acute-phase proteins","volume":"153","author":"Lee","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/1359-6101(96)00019-6","article-title":"Long pentraxins: an emerging group of proteins with diverse functions","volume":"7","author":"Goodman","year":"1996","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB23","doi-asserted-by":"crossref","first-page":"32817","DOI":"10.1074\/jbc.272.52.32817","article-title":"Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component","volume":"272","author":"Bottazzi","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature01195","article-title":"Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response","volume":"420","author":"Garlanda","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.ATV.0000015595.95497.2F","article-title":"Production of the long pentraxin PTX3 in advanced atherosclerotic plaques","volume":"22","author":"Rolph","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB26","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1097\/00002030-200205240-00001","article-title":"Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi\u2019s sarcoma cells","volume":"16","author":"Klouche","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB27","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/00003246-200107000-00017","article-title":"Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients","volume":"29","author":"M\u00fcller","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB28","first-page":"1982","article-title":"Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts","volume":"10","author":"Lee","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1128\/iai.65.4.1345-1350.1997","article-title":"Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan","volume":"65","author":"Vouret-Craviari","year":"1997","journal-title":"Infect Immun."},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB30","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","article-title":"Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes","volume":"84","author":"Alles","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jlb.67.3.387","article-title":"Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages","volume":"67","author":"Goodman","year":"2000","journal-title":"J Leukoc Biol"},{"issue":"163","key":"10.1016\/j.atherosclerosis.2004.03.020_BIB32","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.4049\/jimmunol.163.8.4583","article-title":"Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor","volume":"15","author":"Klouche","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/immu.200310022","article-title":"Biochemical and functional characterization of the interaction between pentraxin 3 and C1q","volume":"33","author":"Nauta","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB34","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V96.13.4300","article-title":"The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells","volume":"96","author":"Rovere","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB35","doi-asserted-by":"crossref","first-page":"13043","DOI":"10.1073\/pnas.192399699","article-title":"C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids","volume":"99","author":"Chang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.102.6.636","article-title":"A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans","volume":"102","author":"Peri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB37","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6","article-title":"Querini PR. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation","volume":"44","author":"Fazzini","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2004.03.020_BIB38","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.ATV.0000012282.39306.64","article-title":"Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation","volume":"22","author":"Napoleone","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004001820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004001820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:18:35Z","timestamp":1762186715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915004001820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0021915004001820"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.03.020","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}